Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017)
Organogenesis Holdings (ORGO) recorded quarterly Income from Non-Controlling Interests of $273000.0 in Q2 2017, down 53.73% quarter-over-quarter from $590000.0 in Q1 2017.
Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017) Analysis & Trends
Organogenesis Holdings' Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $273000.0 for Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 273,000.00 |
| Mar 31, 2017 | 590,000.00 |